Skip to content

Monashee Investment Management LLC

Follow

13F filer, CIK 1627608, Boston, MA

Monashee Investment Management LLC reported $33,404,308 across 16 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-06. Its ten largest share positions make up 88.42% of the portfolio.

Accepted , ingested 13F-HR 0001172661-26-004876

Period
2026-09-30
Reported value
$33.4M
Holdings
16
Top 10 weight
88.42%
New
13
Sold out
20

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AXON ENTERPRISE INCnew+5,000,000$4.94M
IMMXnew+450,000$4.68M
SYYnew+55,000$4.29M
NWCLnew+400,000$3.14M
ENBnew+50,000$2.32M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GOOGMexited-100,000-$5.09M
GOOGNexited-100,000-$5.03M
DLRexited-25,000-$4.49M
SYREexited-50,000-$4.44M
TNGXexited-100,000-$3.13M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001172661-26-004876, largest first. % of portfolio is the value over $33,404,308, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AXON ENTERPRISE INCAXON ENTERPRISE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,000,000 shares 5,000,000$4.94M14.8%new
IMMXIMMIX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000$4.68M14.02%newTimeline
SYYSYSCO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 55,000 shares 55,000$4.29M12.84%newTimeline
NWCLNEWCLEO PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 400,000 shares 400,000$3.14M9.4%newTimeline
ADTADT INC DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 575,000 shares; 2025Q2: 600,406 shares; 2025Q3: 450,000 shares; 2025Q4: 400,000 shares; 2026Q1: 700,000 shares; 2026Q2: 600,000 shares; 2026Q3: 500,000 shares 500,000$3.04M9.1%-100,000Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 480,000 shares; 2025Q1: 1,673,412 shares; 2025Q2: 2,165,000 shares; 2025Q3: not reported; 2025Q4: 1,349,771 shares; 2026Q1: 1,420,295 shares; 2026Q2: 500,000 shares; 2026Q3: 410,000 shares 410,000$2.96M8.87%-90,000Timeline
ENBENBRIDGE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$2.32M6.96%newTimeline
VIKING THERAPEUTICS INCVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,500,000 shares 1,500,000$1.54M4.6%new
BLSMBLOSSOMHILL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 80,000 shares 80,000$1.49M4.46%newTimeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$1.12M3.37%newTimeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 40,000 shares 40,000$901K2.7%newTimeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 91,621 shares; 2026Q1: not reported; 2026Q2: 192,344 shares; 2026Q3: 177,094 shares 177,094$811K2.43%-15,250Timeline
AVAHAVEANNA HEALTHCARE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$620K1.86%newTimeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 229,310 shares 229,310$534K1.6%newTimeline
OIGORION180 INS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 55,000 shares 55,000$530K1.59%newTimeline
HGTYHAGERTY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 35,000 shares 35,000$471K1.41%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GOOGMALPHABET INC100,000$5.09Mshares
GOOGNALPHABET INC100,000$5.03Mshares
DLRDIGITAL RLTY TR INC25,000$4.49Mshares
SYRESPYRE THERAPEUTICS INC50,000$4.44Mshares
TNGXTANGO THERAPEUTICS INC100,000$3.13Mshares
CELCUITY INCCELCUITY INC2,500,000$2.84Mprincipal
SMCIPSUPER MICRO COMPUTER INC50,000$2.6Mshares
LEGNLEGEND BIOTECH CORP85,385$2.47Mshares
GOOGLALPHABET INC6,000$2.14Mshares
GOOGALPHABET INC6,000$2.12Mshares
QUREUNIQURE NV45,000$2.07Mshares
INIOINNIO NV47,650$1.88Mshares
AKRACADIA RLTY TR85,385$1.79Mshares
PTRNPATTERN GROUP INC64,039$1.61Mshares
PURECYCLE TECHNOLOGIES INCPURECYCLE TECHNOLOGIES INC1,500,000$1.53Mprincipal
MLTXMOONLAKE IMMUNOTHERAPEUTICS75,000$1.46Mshares
WHKWHITEHAWK MINERALS CORP51,232$1.43Mshares
TSHATAYSHA GENE THERAPIES INC200,000$1.36Mshares
NUVATION BIO INCNUVATION BIO INC1,000,000$1.06Mprincipal
KARDKARDIGAN INC42,693$1.02Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-004876 base2026-11-06